期刊文献+

辛伐他汀联合吡喃阿霉素对肝癌SMMC-7721细胞的协同抑制作用 被引量:1

The effect of simvastatin plus priarubicin on proliferation of liver cancer cell line SMMC-7721
下载PDF
导出
摘要 目的:研究辛伐他汀联合吡喃阿霉素对人肝癌细胞SMMC-7721的增殖抑制作用。方法:辛伐他汀、吡喃阿霉素分别及联合处理细胞48小时,MTT法测量细胞的增殖抑制,按公式计算相互作用指数。结果:按照文献报道计算相互作用指数,相互作用指数小于1。结论:辛伐他汀和吡喃阿霉素对于SMMC-7721有协同抗瘤作用。 Objective:To examine the interaction effect of simvastatin and priarubicin on proliferation ability of SMMC -7721. Methods:After treated SMMC -7721 cell with simvastatin and priarubicin 48 hours, proliferation of SMMC- 7721 were examined with MTT test. Results:The interaction index for simvastatin and priarubicin used in combination in SMMC -7721 was 0.71. Conclusion :The combination therapy with simvastatin and priarubicin may be due to the synergistic interaction of these two drags.
作者 杨士杰
出处 《现代肿瘤医学》 CAS 2012年第7期1343-1344,共2页 Journal of Modern Oncology
关键词 辛伐他汀 肝癌 SMMC-7721 simvastatin liver cancer SMMC - 7721
  • 相关文献

参考文献8

  • 1Marco Raiteri, Lorenzo Arnaboldi, Paul Mcgeady, et al. Pharmacological control of the mevalonate pathway : effect on arterial smooth muscle cell proliferation[J]. JPET , 1997, 281 ( 3 ) : 1144 - 1153.
  • 2Berenbaum MC. Criteria for analyzing interactions between biologically activeagents [ J ]. Adv Cancer Res, 1981,35:269 - 336.
  • 3arc Bardou, Alan Barkun, Myriam Martel. Effect of statin therapy on colorectal cancer[J]. Gut Nov,2010,59:1572 - 1585.
  • 4Buchwald H. Cholesterol inhibition, cancer and chemotherapy [ J ]. Lancet, 1992,339 : 1154 - 1156.
  • 5Jody M. Statin use is associated with a reduced risk of colon cancer recurrence[J]. J Clinical Oncol,2007,25 (18s) :4114.
  • 6Thomas P Ahem, Lars Pedersen, Maja Tarp. Statin prescriptionsand reast cancer recurrence risk: a Danish nationwide prospective cohort study[ J]. J Natl Cancer Inst,2011,10 : 1093.
  • 7Sarah A Holstein, Christine L, Wohlford- Lenane,et al. Consequences of mevalonate depletion [ J ]. J Biol Chem,2002,277 ( 12 ) : 10678 - 10682.
  • 8Wojciech Feleszko, Izabela Ynarczuk, Ewa Z. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice [ J ]. Clin Cancer Res,2000,6 : 2044 - 2052.

同被引文献14

  • 1Siegel R,Naishadham Djemal A. Cancer statistics 2012[J]. Cancer J Clin,2012,62:10-29.
  • 2Ferlay J, Shin HR ,Bray F,et al. Estimates of worldwide burden of cancer in 2008: Globocau 2008[J]. International Journal of Cancer,2010,127(2):2893-917.
  • 3Liu H,Wan g Z,Li Y,et al. Pravastatin prevents proliferation and bone metastases of lung adenocarcinoma in vitro and in vivo[J], Neoplasma,2013,60(3):240-246.
  • 4Shen YY,Yuan Y,Du YY,et al. Molecular mechanism underlying the anticancer effect of pravastatin on MDA-MB-231 human breast cancer cells[J]. Molecular Medicine Reports ,2015,12(1):623-630.
  • 5Osmak M. Statins and cancer: Current and future prospects[J]. Cancer Lett,2012,324(1);1-12.
  • 6Reboulleau A, Robert V, Vedie B , et al. Involvement of cholesterol efflux pathway in the control of cardiomyocytes cholesterol homeostasis[J]. J Mol Cell Cardiol,2012,53:196-205.
  • 7Garcia-Ruiz C, Morales A, Fernandez-Checa JC. Statins and protein prenylation in ancer cell biology and therapy[J]. Anticancer Agents Med Chem,2012,12:303-315.
  • 8W. Gibson Wood,Urule lgbavboa,Walter E. Muller,et al.Statins,Bcl-2 and Apopiosis:Cell Death or Cell Protection?[J], Mol Neurobiol,2013,48(2);308-314.
  • 9Chen J,Liu B,Yuan J,et al. Atorvastatin reduces vascular endothelial growth factor (VEGF)expression in human non-small cell lung carcinomas (NSCLCs)via inhibition of reactive oxygen species (ROS)production[J]. Molecular Oncology,2012,6(1):62-72.
  • 10Zhu Y,Casey PJ,Kumar AP. Deciphering the signaling networks underlying pravastatin -induced apoptosis in human cancer cells : Evidence for non -canonical activa tion of RhoA and Racl GTPases[J]. Cell Death Dis,2013,4(4):e568.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部